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Chlorine has been used as a disinfection agent
for raw water supplies since the early 1900s
(Wigle 1998). Chlorination is presently the
most common procedure used for water treat-
ment worldwide. Its widespread use has been
credited with largely eliminating the risk of ill-
nesses caused by cholera and other micro-
biologic contaminants in drinking water.
Despite the effectiveness of chlorine in pre-
venting morbidity and mortality due to water-
borne pathogens, there remains concern about
possible adverse health effects associated with
chronic exposure to chlorination disinfection
by-products (CDBPs) present in drinking
water and, in particular, about the carcino-
genic potential of CDBPs (Bellar et al. 1974;
Krewski et al. 2002; Rook 1974).
Chlorine reacts with naturally occurring
organic material in raw water supplies to pro-
duce a variety of CDBPs that can be grouped
together based on molecular structure. The
most common are trihalomethanes (THMs),
haloacetic acids, and haloacetonitriles. THMs
(the most abundant CDBP) consist of four
species: chloroform (TCM), bromodichloro-
methane (BDCM), dibromochloromethane,
and bromoform.
Although animal studies have consistently
shown an association between THMs and
both liver and kidney cancer (Dunnick and
Melnick 1993), evidence of human carcino-
genicity is limited. In a 1992 review of the lit-
erature concerning cancer risk after CDBP
exposure, Morris et al. (1992) reported evi-
dence of an increased risk only for bladder
cancer [odds ratio (OR) = 1.41; 95% confi-
dence interval (95% CI), 1.25–1.62] and rec-
tal cancer (OR = 2.04; 95% CI, 1.16–3.53).
Subsequently, three population-based
case–control studies of CDBPs and bladder
cancer reported statistically elevated risk with
ORs in the range of 1.6–1.8 (Cantor et al.
1998; King and Marrett 1996; McGeehin
et al. 1993). However, the increased risk for
colon cancer identiﬁed by Morris et al. (1992)
has not been conﬁrmed in later studies (King
et al. 2000).
The role of CDBPs in the etiology of pan-
creatic cancer has been less well investigated.
Pancreatic cancer is the fourth leading cause of
cancer mortality in Canada and the United
States, with an annual incidence rate of
approximately 9/100,000 (Ahlgren 1996;
National Cancer Institute of Canada 2002).
The etiology of pancreatic cancer remains
largely unknown, with only age and tobacco
smoking having been consistently identiﬁed as
risk factors for this lesion (Ghadirian et al.
2003; Risch 2003). Chronic pancreatitis, obe-
sity, diabetes mellitus, excess alcohol intake,
meat intake, and reproductive factors in
women have also been linked to pancreatic
cancer risk, although the epidemiologic evi-
dence is somewhat inconsistent (Anderson
et al. 2002; Kreiger et al. 2001; Risch 2003).
In their review, Morris et al. (1992) iden-
tified six studies of CDBPs and pancreatic
cancer. A combined analysis from these studies
yielded a pooled OR of 1.05 (95% CI,
0.91–1.22). In a case–control study involving
101 cases, IJsselmuiden et al. (1992) subse-
quently found an OR of 2.23 (95% CI,
1.20–3.95) for people using municipal (chlori-
nated) water compared with people using non-
municipal (nonchlorinated) water. In contrast,
a case–control study conducted by Kukkula and
Lofroth (1997) found a reduced risk of pan-
creatic cancer (OR = 0.20; 95% CI, 0.04–0.94)
among those with chlorinated municipal
drinking water from a surface source.
In this article, we report the results of a
large population-based case–control study of
incident pancreatic cancer cases derived from
the National Enhanced Cancer Surveillance
System (NECSS) of Canada. Individual expo-
sures were estimated using two different data-
bases containing information on CDBPs in
municipal drinking water in Canada. One
database provided time-dependent total THM
concentrations, whereas the other provided
single estimates of exposure to two specific
THMs (TCM and BDCM) representing the
entire study period.
Materials and Methods
Recruitment of subjects. The NECSS was a
collaborative effort between Health Canada
and the Provincial Cancer Registries, which
recruited, between 1994 and 1997, a total of
20,755 incident cases of 18 types of cancer
(including 628 cases of pancreatic cancer) and
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Chlorination disinfection by-products (CDBPs) are produced during the treatment of water with
chlorine to remove bacterial contamination. CDBPs have been associated with an increased risk of
bladder cancer. There is also some evidence that they may increase the risk of pancreatic cancer.
We report results from a population-based case–control study of 486 incident cases of pancreatic
cancer and 3,596 age- and sex-matched controls. Exposure to chlorination by-products was esti-
mated by linking lifetime residential histories to two different databases containing information
on CDBP levels in municipal water supplies. Logistic regression analysis found no evidence of
increased pancreatic cancer risk at higher CDBP concentrations (all odds ratios < 1.3). Null ﬁnd-
ings were also obtained assuming a latency period for pancreatic cancer induction of 3, 8, or 13
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[Online 10 January 2005]5,039 population-based controls who were
frequency matched to the overall case group
on age (5-year groups) and sex. Permission to
contact the subjects was obtained from the
attending physician. Two different strategies
were used to identify controls: random selec-
tion from universal provincial health insurance
plan rosters or provincial tax assessment roles,
and random digit dialing. Interviews were
conducted by mail, with the study question-
naire being mailed to cases within 1–4 months
of diagnosis. Three of the eight participating
provinces (Ontario, Nova Scotia, and Alberta)
allowed the questionnaire to be completed by
a proxy, most often a spouse, when the case
had died or was too ill to complete the ques-
tionnaire. Overall, 24.8% of interviews for
cases were provided by proxies. Because
excluding proxy responses from the analysis
did not affect the results, we retained proxy
responses in all analyses reported in this arti-
cle. Further details of the NECSS study are
provided by Johnson and colleagues (Johnson
2000; Johnson et al. 1998).
The primary analytic sample for the pre-
sent study was restricted to subjects between
30 and 75 years of age who lived in one of six
Canadian provinces (Nova Scotia, Ontario,
Manitoba, Saskatchewan, Alberta, and British
Columbia) at the time of interview. Prince
Edward Island and Newfoundland were
excluded from the primary analyses because of
small numbers. Of the cases who were mailed
a questionnaire, 70% agreed to participate.
The response rate among contacted controls
was 65%. Cases were eligible for the study if
this was their first cancer and their cancer
diagnosis codes were either 157 [International
Classification of Diseases, 9th Revision;
World Health Organization (1977)] or C25
[International Classification of Oncology, ver-
sion 2; Percy et al. (1990)]. Subjects were
excluded if they had missing or invalid age
information (n = 9), missing province of resi-
dence (n = 4), or inconsistent residence infor-
mation (n = 292). One case who did not have
pancreatic cancer was also excluded. This
yielded a study sample size, before excluding
subjects with missing values, of 576 cases and
4,105 controls.
The survey instrument contained questions
about lifestyle factors, anthropometric meas-
ures, a 69-item food frequency questionnaire,
and a detailed residence history. This last com-
ponent asked subjects to record every address
where they had lived at for at least 12 months,
from birth to the date of the interview. For
each location at which the subjects had lived,
they were asked to record the time period (year
they moved into the residence and the year
they left the residence), street, city, county/
district, province, postal code (if available), and
the main source of drinking water (town, dug
well, drilled well, bottled, other).
Exposure measurement. CDBP exposure
was estimated by linking information about res-
idences to databases providing estimates of
CDBP levels in municipal water supplies. All
people receiving water from the same source
were assumed to have been exposed to the same
CDBP levels. Two linkage ﬁles were used. The
first, the Environmental Health Directorate
(EHD) file, provided summary information
about three CDBPs (THM, TCM, and
BDCM) but did not provide residence-speciﬁc
exposures, which limited analysis of latency
periods. The second, the Provincial and
Municipal Water Monitoring (PMW) ﬁle, con-
tained information about only one CDBP
(THM) but included data on THM levels for
different residences occupied by the study sub-
jects. The EHD file was created by Health
Canada using estimates of CDBP levels based
on four surveys of water treatment facilities in
650 municipalities that had been conducted in
1962, 1975, 1988, and 1995. These surveys
were supplemented by estimates from the 1993
National Survey of Chlorination Disinfection
By-products, which collected water samples
from 53 major cities in Canada and measured
CDBP levels in these samples (Health Canada
1995). Health Canada had access to residence-
speciﬁc information that was used to estimate
average CDBP exposure levels between 1940
and 3 years before the interview. Although this
average exposure metric was available to us for
analysis, the residence-specific levels were
unavailable for reasons of conﬁdentiality.
The second linkage ﬁle was based on pub-
lic domain information (the PMW ﬁle) (King
and Marrett 1996). This file was based on
reports from municipal water treatment facili-
ties between 1990 and 1993. In order to
extend the geographic coverage of this ﬁle, we
used the Municipal Water Use Database
(MUD) to estimate THM concentrations in
drinking water (King et al. 2000). The MUD
does not directly contain information about
CDBPs. Rather, it contains information
about water source and treatment practices
for all communities in Canada with a popula-
tion of at least 1,000. A linear regression
model with an R2 of 0.76 was used to predict
THM levels in a community, based on water
source, treatment practices, and hydrologic
characteristics of the community (King W,
personal communication). Although only
total THM levels could be estimated from the
PMW ﬁle, information was available for each
residence occupied by the study subjects.
Because both ﬁles provide an estimate of
THM exposure in the 30-year exposure time
window (ETW) ending 3 years before inter-
view, we compared the estimates to document
the similarity of the estimation methods. The
Pearson correlation between the THM con-
centrations was 0.96. The concordance in
classification of THM concentrations into
the exposure groups used in our analyses was
also high, with Cohen’s (unweighted) kappa
being 0.82.
Individual exposure assignment was based
on a predetermined ETW of 30 years ending
3 years before the year of interview. In most
instances, the ETW corresponds to the period
1963–1993. Subjects using well water or bot-
tled water as their primary source of water were
assigned a THM exposure of zero for that resi-
dence. There was no information provided
about the use of charcoal filters that might
reduce CDBP levels. For the EHD file, the
CDBP concentrations available to us repre-
sented a 40-year exposure period. This was
adjusted to a 30-year ETW by computing a
weighted average of the average THM expo-
sure for years lived in a residence using munici-
pal water and a value of zero for years lived in
residence with well or bottled water. For the
PMW ﬁle, exposure was obtained by averaging
the annual exposure levels for each of the years
within the ETW.
CDBP levels were analyzed after categoriz-
ing the exposure into four groups based on cut-
points used in previously published studies. For
THM, the exposure groups were < 10 µg/L,
10–20 µg/L, 20–50 µg/L, and > 50 µg/L. For
TCM, the exposure groups were < 3 µg/L,
3–10 µg/L, 10–30 µg/L, and > 30 µg/L. For
BDCM, the exposure groups were < 1 µg/L,
1–3 µg/L, 3–5 µg/L, and > 5 µg/L. The referent
group was the lowest exposure group in all
analyses.
In a secondary analysis we examined
THM levels in the PMW file weighted by
reported weekly intake of tap water. In this
analysis, THM exposure was divided into
quartiles, with the upper quartile being fur-
ther divided into two groups using the 50th
percentile of exposure within the upper quar-
tile. (We do not provide the numerical cut-
points because the weighted THM levels have
no direct interpretation.)
Dietary factors (total daily caloric intake
and total daily fat intake) were estimated using
the method used by Villeneuve et al. (1999).
Analysis. The distributions of the expo-
sures and potential confounders were explored
using descriptive statistics. Unconditional
logistic regression analysis was used to explore
the effect of CDBP exposure on pancreatic
cancer risk. All models adjusted for the three
matching variables (age group, sex, and
province of residence) and for body mass
index (BMI); percent weight change; smok-
ing, coffee, beer, liquor, and total fat intake;
and energy intake. Analyses restricted to
females were also adjusted for age at first
menstruation and number of pregnancies. All
continuous confounders were categorized into
quartiles before analysis based on their distrib-
ution in the combined group of cases and
controls. Effect modification by sex was
Article | Chlorination by-products and pancreatic cancer
Environmental Health Perspectives • VOLUME 113 | NUMBER 4 | April 2005 419explored by ﬁtting separate logistic regression
models for males and for females.
Observed control mean imputation
(OCMI) (Weinberg et al. 1996) was used to
impute exposures when subjects had missing
or incomplete residence information. In this
method, subjects for whom a CDBP exposure
could not be computed because of missing
data were assigned a CDBP level based on the
average CDBP concentration observed in the
control group. For the EHD ﬁle, imputation
was done only when subjects failed to report
their residence for ≥ 1 year. For the PMW ﬁle,
exposures were imputed if a residence had
been omitted or if there was no THM level
available in the THM reference ﬁle for a spe-
ciﬁc residence. As a result, the level of imputa-
tion was higher in the PMW file (35–50%)
than in the EHD file (24%). The effect of
imputation was examined by comparing the
OCMI-based results with those obtained
using case-wise deletion of subjects with miss-
ing THM exposures. The two analyses pro-
duced similar results: although some ORs
changed by 15–20%, overall statistical signiﬁ-
cance and exposure–response trends did not
change appreciably. Consequently, we report
here only those results based on OCMI.
The effect of exposure latency was explored
using the annual exposure data available in the
PMW file. Three analyses were conducted
using latency periods of 3, 8, and 13 years. For
example, in the 8-year latency analysis, expo-
sure was based only on residences occupied in
the period 8–33 years before interview. The
EHD analyses incorporated a fixed 3-year
latency period in the exposure assessment.
Results
The study population included 576 cases and
4,105 controls, with a male-to-female case ratio
of 1.29 (Table 1). As expected, the number of
Article | Do et al.
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Table 1. Descriptive statistics and ORs for selected subject characteristics.
Male and female Male Female
Characteristic Casesa Controlsa ORb (95% CI) Casesa Controlsa ORc (95% CI) Casesa Controlsa ORc (95% CI)
Sex
Male 324 (56) 2,066 (50) Matching
Female 252 (44) 2,039 (50) variable
Both 576 4,105
Age (years)
< 50 67 (12) 1,062 (26) 36 (11) 417 (20) 31 (12) 645 (32)
50–54 52 (9) 358 (9) 29 (9) 132 (6) 23 (9) 226 (11)
55–59 77 (13) 417 (10) Matching 45 (14) 192 (9) Matching 32 (13) 225 (11) Matching
60–64 107 (19) 614 (15) variable 62 (19) 317 (15) variable 45 (18) 297 (15) variable
65–69 138 (24) 804 (20) 77 (24) 481 (23) 61 (24) 323 (16)
≥ 70 135 (23) 850 (21) 75 (23) 527 (26) 60 (24) 323 (16)
All 576 4,105 324 2,066 252 2,039
Smoking (pack-years)
0 180 (32) 1,548 (38) 1.00d  70 (23) 525 (26) 1.00d  110 (45) 1,023 (51)  1.00d 
1–15 115 (21) 1,197 (30) 0.86 (0.67–1.11) 61 (20) 630 (31) 0.70 (0.49–1.01) 54 (22) 567 (28) 1.04 (0.73–1.47)
15–35 167 (30) 872 (22) 1.55 (1.22–1.96) 107 (34) 538 (27) 1.35 (0.97–1.89) 60 (24) 334 (17) 1.79 (1.26–2.52)
> 35 95 (17) 411 (10) 1.76 (1.32–2.35) 73 (23) 330 (16) 1.66 (1.15–2.41) 22 (9) 81 (4) 2.07 (1.23–3.49)
Missing 19 77 13 43 6 34
All 576 4,105 324 2,066 252 2,039
BMI (kg/m2)
< 23 146 (26) 1,150 (28) 1.00d  59 (18) 396 (19) 1.00d  87 (35) 754 (37) 1.00d 
23–27 203 (36) 1,618 (40) 0.87 (0.69–1.09) 127 (40) 915 (45) 0.89 (0.64–1.24) 76 (30) 703 (35) 0.79 (0.57–1.10)
27–30 104 (18) 749 (18) 0.93 (0.71–1.23) 71 (22) 444 (22) 0.99 (0.68–1.44) 33 (13) 305 (15) 0.76 (0.50–1.17)
> 30 118 (21) 566 (14) 1.45 (1.11–1.91) 63 (19) 299 (15) 1.30 (0.88–1.93) 55 (22) 267 (13) 1.63 (1.12–2.37)
Missing 5 22 4 12 1 10
All 576 4,105 324 2,066 252 2,039
Percent weight changee
< 2.9 187 (33) 930 (23) 1.00d  108 (34) 529 (26) 1.00d  79 (32) 401 (20) 1.00d 
2.9–5.7 108 (19) 1,014 (25) 0.53 (0.41–0.68) 65 (20) 571 (28) 0.57 (0.41–0.79) 43 (17) 443 (22) 0.49 (0.33–0.73)
5.7–10.2 140 (25) 1,147 (28) 0.64 (0.50–0.81) 72 (23) 530 (26) 0.66 (0.48–0.92) 68 (27) 617 (31) 0.59 (0.41–0.84)
> 10.2 133 (23) 971 (24) 0.74 (0.58–0.95) 74 (23) 411 (20) 0.92 (0.66–1.27) 59 (24) 560 (28) 0.59 (0.41–0.86)
Missing 8 43 5 25 3 18
All 576 4,105 324 2,066 252 2,039
Coffee (cups)
≤ 4 cups/week 64 (11) 513 (13) 1.00d  30 (9) 217 (11) 1.00d  34 (14) 296 (15) 1.00d 
5–7 cups/week 146 (26) 1,131 (28) 0.87 (0.63–1.19) 71 (22) 575 (28) 0.77 (0.48–1.23) 75 (30) 556 (28) 0.98 (0.64–1.53)
2–3 cups/day 204 (36) 1,538 (38) 0.87 (0.64–1.18) 122 (38) 775 (38) 0.93 (0.60–1.44) 82 (33) 763 (38) 0.78 (0.51–1.21)
> 3 cups/day 152 (27) 850 (21) 1.21 (0.88–1.67) 97 (30) 465 (23) 1.26 (0.80–1.98) 55 (22) 385 (19) 1.14 (0.71–1.82)
Missing 10 73 4 34 6 39
All 576 4,105 324 2,066 252 2,039
Beer (servings)
0–3/month 398 (73) 3,100 (79) 1.00d  189 (61) 1,333 (67) 1.00d  209 (90) 1,767 (91) 1.00d 
1–6/week 54 (10) 336 (8) 1.28 (0.94–1.76) 42 (14) 239 (12) 1.25 (0.87–1.81) 12 (5) 97 (5) 1.31 (0.70–2.48)
≥ 1 per day 91 (17) 508 (13) 1.41 (1.09–1.84) 77 (25) 429 (21) 1.28 (0.95–1.72) 14 (6) 79 (4) 1.67 (0.92–3.05)
Missing 33 161 16 65 17 96
All 576 4,105 324 2,066 252 2,039
Wine (glasses)
0–3/month 444 (81) 3,290 (83) 1.00d  241 (79) 1,631 (82) 1.00d  203 (85) 1,659 (84) 1.00d 
1–6/week 48 (9) 307 (8) 1.21 (0.87–1.67) 26 (8) 144 (7) 1.16 (0.75–1.82) 22 (9) 163 (8) 1.27 (0.78–2.05)
≥ 1 per day 55 (10) 357 (9) 1.04 (0.76–1.41) 40 (13) 206 (10) 1.20 (0.83–1.74) 15 (6) 151 (8) 0.76 (0.44–1.34)
Missing 29 151 17 85 12 66
All 576 4,105 324 2,066 252 2,039
Continued, next pagepancreatic cancer cases increased with age.
The results of univariate logistic regression
modeling of selected covariates (adjusted for
age, sex, and province) are shown in Table 1.
These results confirm the increased risk of
pancreatic cancer associated with smoking,
with the risk being signiﬁcantly elevated in the
highest two quartiles of smoking. There was
some evidence of increased risk of pancreatic
cancer in relation to higher body mass index
(BMI; for BMI > 30 kg/m2, OR = 1.45; 95%
CI, 1.11–1.91). There was a consistently
lower risk of pancreatic cancer in relation to
larger discrepancies between peak lifetime
weight and weight reported 2 years before
interview (OR = 0.72; 95% CI, 0.57–0.90).
Beer (OR = 1.41; 95% CI, 1.09–1.84) and
liquor intake (OR = 1.34; 95% CI,
1.03–1.75) were associated with increased
pancreatic cancer risk, although the latter
effect appeared to be conﬁned to males. Wine
consumption was not associated with pancre-
atic cancer risk in either men or women.
There was some evidence of an increased risk
of pancreatic cancer in relationship to total fat
and total caloric intake, although these results
were of marginal statistical significance.
Consumption of tap water was not associated
with pancreatic cancer. Neither educational
attainment nor age at menarche was related to
pancreatic cancer risk. Women who reported
more than four pregnancies were at reduced
risk of pancreatic cancer; this result is explored
more fully by Kreiger et al. (2001).
Multivariate models (data not shown)
confirmed the increased risk associated with
smoking and the decreased risk associated
with weight discrepancy. The effect of alcohol
was largely eliminated after multivariate
adjustment for other covariates.
Average THM levels in drinking water
consumed by the study subjects varied by
province, ranging from a low of 17 µg/L in
Ontario to a high of 74 µg/L in Manitoba.
Subjects in Manitoba also had the highest
average levels of TCM (66 µg/L compared
with between 11 and 22 µg/L in other
provinces). BDCM exposure was more homo-
geneous, ranging from about 1.5 µg/L in
British Columbia and Alberta to 5.8 µg/L in
Manitoba and Saskatchewan. Average total
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Table 1. Continued
Male and female Male Female
Characteristic Casesa Controlsa ORb (95% CI) Casesa Controlsa ORc (95% CI) Casesa Controlsa ORc (95% CI)
Liquor (ounces)
0–3/month 433 (78) 3,248 (82) 1.00d  217 (70) 1,489 (74) 1.00d  214 (88) 1,759 (89) 1.00d 
1–6/week 40 (7) 328 (8) 0.86 (0.61–1.23) 24 (8) 234 (12) 0.67 (0.43–1.06) 16 (7) 94 (5) 1.47 (0.84–2.57)
≥ 1 per day 83 (15) 408 (10) 1.34 (1.03–1.75) 69 (22) 284 (14) 1.60 (1.18–2.17) 14 (6) 124 (6) 0.85 (0.47–1.51)
Missing 22 121 14 59 8 62
All 576 4,105 324 2,066 252 2,039
Total fat intake (g/week)
< 236 108 (21) 906 (24) 1.00d  55 (19) 368 (20) 1.00d  53 (24) 538 (29) 1.00d 
236–323 116 (23) 925 (25) 1.06 (0.80–1.41) 52 (18) 426 (23) 0.81 (0.54–1.22) 64 (29) 499 (27) 1.39 (0.94–2.05)
324–420 129 (25) 899 (24) 1.21 (0.92–1.60) 81 (28) 457 (25) 1.24 (0.85–1.80) 48 (22) 442 (24) 1.12 (0.74–1.71)
> 420 160 (31) 998 (27) 1.34 (1.03–1.75) 105 (36) 598 (32) 1.22 (0.85–1.74) 55 (25) 400 (21) 1.44 (0.96–2.16)
Missing 63 377 31 217 32 160
All 576 4,105 324 2,066 252 2,039
Total energy intake (calories/week)
< 1,370 121 (24) 1,039 (28) 1.00d  60 (20) 433 (23) 1.00d  61 (28) 606 (32) 1.00d 
1,371–1,710 111 (22) 967 (26) 0.96 (0.73–1.27) 49 (17) 456 (25) 0.77 (0.51–1.15) 62 (29) 511 (27) 1.16 (0.80–1.69)
1,711–2,050 127 (25) 760 (20) 1.44 (1.10–1.88) 73 (25) 372 (20) 1.41 (0.97–2.05) 54 (25) 388 (21) 1.44 (0.97–2.13)
> 2,050 154 (30) 962 (26) 1.30 (1.01–1.69) 111 (38) 588 (32) 1.39 (0.98–1.95) 43 (20) 374 (20) 1.10 (0.72–1.67)
Missing 63 377 31 217 32 160
All 576 4,105 324 2,066 252 2,039
Tap water (glasses/week)
< 1 90 (16) 687 (17) 1.00d  44 (14) 354 (18) 1.00d  46 (19) 333 (17) 1.00d 
1–7 128 (23) 1,001 (25) 0.97 (0.73–1.30) 74 (24) 536 (27) 1.08 (0.72–1.61) 54 (22) 465 (23) 0.87 (0.57–1.33)
7–21 202 (36) 1,247 (31) 1.16 (0.89–1.52) 125 (40) 658 (33) 1.47 (1.01–2.13) 77 (31) 589 (29) 0.87 (0.58–1.29)
> 21 139 (25) 1,075 (27) 0.94 (0.70–1.25) 71 (23) 463 (23) 1.18 (0.78–1.77) 68 (28) 612 (31) 0.72 (0.48–1.08)
Missing 17 95 10 55 7 40
All 576 4,105 324 2,066 252 2,039
Education (total years)
< 9 95 (17) 652 (16) 1.00d  66 (21) 393 (19) 1.00d  29 (12) 259 (13) 1.00d 
9–12 281 (50) 1,770 (44) 1.23 (0.96–1.59) 145 (46) 842 (41) 1.04 (0.75–1.43) 136 (56) 928 (46) 1.57 (1.02–2.42)
> 12 187 (33) 1,624 (40) 0.99 (0.75–1.30) 107 (34) 797 (39) 0.84 (0.60–1.19) 80 (33) 827 (41) 1.27 (0.80–2.01)
Missing 13 59 6 34 7 25
All 576 4,105 324 2,066 252 2,039
Age at menarche (years)
< 12 32 (17) 329 (17) 1.00d 
12–15 137 (71) 1,271 (67) 1.06 (0.70–1.60)
> 15 24 (12) 285 (15) 0.75 (0.43–1.32)
Missing 59 154
All 252 2,039
Parity
0 31 (11) 221 (11) 1.00d 
1 21 (8) 161 (8) 0.96 (0.52–1.76)
2 60 (24) 498 (24) 0.93 (0.58–1.49)
3 55 (22) 410 (20) 0.91 (0.56–1.47)
≥ 4 85 (34) 744 (37) 0.63 (0.40–0.98)
Missing 05
All 252 2,039
aNumber of cases (percentage of total excluding cases with missing values). bOverall ORs adjusted for age, sex, and province. cSex-specific ORs adjusted for age and province.
dReferent group. ePercent decrease of present weight compared with maximum lifetime weight.THM levels for males and females were similar
(25.2 vs. 23.7 µg/L, respectively), as were
TCM (19.9 vs. 18.6 µg/L) and BDCM levels
(3.2 vs. 3.2 µg/L). CDBP levels were similar
across the study age groups, ranging from 23 to
25 µg/L for THM, from 18.4 to 20.4 µg/L for
TCM, and around 3.1 µg/L in all age groups
for BDCM. The mean CDBP levels were simi-
lar in the cases and controls: 24.3 versus
24.5 µg/L for THM, 19.5 versus 19.3 µg/L for
TCM, and 3.1 versus 3.2 µg/L for BDCM.
ORs for pancreatic cancer risk in relation
to exposure to THMs, BDCMs, and TCMs
based on the EHD data file are shown in
Table 2. Overall, these results provide little
evidence of an association between CDBPs
and pancreatic cancer. None of the tests for
heterogeneity among the ORs in the CDBP
exposure categories was statistically signifi-
cant, nor was there any evidence of increasing
trend in the ORs with increasing CDBP lev-
els. For two analyses (THM in females and
TCM for males), the test for heterogeneity
approached a nominal p-value of 0.05.
However, none of the ORs was significantly
elevated, and there was no exposure gradient.
ORs for pancreatic cancer risk in relation-
ship to THM levels based on the PMW data
ﬁle are shown in Table 3. As with the EHD
ﬁle, there was no evidence of heterogeneity in
risk among the THM exposure categories for
any of the three latency periods considered.
The ORs did not suggest a pattern of increas-
ing risk with higher THM levels.
The effect of weighting the level of THM
exposure by a self-reported estimate of the
amount of tap water drunk per day is shown in
Table 4. All of the ORs were close to 1.0, with
none of the results being statistically signiﬁcant.
Discussion
In the present study we found no evidence of
an association between exposure to CDBPs in
drinking water and the risk of pancreatic can-
cer. We did detect a signiﬁcant effect of smok-
ing on pancreatic cancer risk, although the
magnitude of the risk was lower than has been
reported in other studies. We also observed a
reduction in risk in people who reported that
their weight 2 years before their interview was
lower than their peak lifetime weight.
The present analysis, based on about
480 incident pancreatic cancer cases, repre-
sents the largest such study conducted to date,
notably larger than the previous studies of
IJsselmuiden et al. (1992) and Kukkula and
Lofroth (1997), which involved 101 and
183 incident cases, respectively. Although
some studies based on decedent cases have had
substantially larger case groups (up to 4,500),
there is risk of bias when using the residence at
the time of death as the basis for estimating
lifetime CDBP exposure. Our study, which
was based on estimates of average annual
exposure based on self-reported lifetime resi-
dence histories, should provide a better indica-
tion of exposure to CDBPs in drinking water.
Given the strength of our exposure data and
the large sample size, our results suggest that
CDBP exposure is unlikely to be a major risk
factor for pancreatic cancer. The mean level in
our study of the most common CDBP
(THM, 24 µg/L) is similar to that reported in
other studies from Iowa (Cantor et al. 1998)
and Colorado (McGeehin et al. 1993)
Since 1978, 11 studies have explored the
relationship of CDBPs and pancreatic cancer.
These include two ecologic studies (Flaten
1992; Koivusalo et al. 1995), two cohort
studies (Koivusalo et al. 1997; Wilkins and
Comstock 2004), and seven case–control
studies, of which ﬁve relied on decedent cases
(Alavanja et al. 1978; Brenniman et al. 1978;
Gottlieb et al. 1982; Young et al. 1981;
Zierler et al. 1986) and the other two used
incident cases (IJsselmuiden et al. 1992;
Kukkula and Lofroth 1997). Exposure esti-
mates in all of these case–control studies were
based on CDBP levels at a single residence, in
many cases relying on a coarse classiﬁcation of
whether or not municipal water was available
in the house.
The two case–control studies that used
incident cases found conflicting results.
IJsselmuiden et al. (1992) found an elevated
risk associated with CDBP exposure (OR =
2.18; 95% CI, 1.20–3.95). Although Kukkula
and Lofroth (1997) reported a protective
effect in their case–control study, this has not
been replicated in other studies of pancreatic
cancer. Neither of the cohort studies employed
individual exposure measures; rather, exposure
was inferred from access to municipal water
supplies.
Wilkins and Comstock (2004) followed a
cohort of 31,000 subjects for 12 years, with
exposure status determined at recruitment.
No significant differences were observed
Article | Do et al.
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Table 2. ORs for pancreatic cancer in relation to the concentration of CDBPs in drinking water (based on the EHD data set, 30-year ETW, full OCMI imputation,
3-year latency).
CDBP concentration Male and femalea Malea Femaleb
(µg/L) Cases Controls OR (95% CI) Cases Controls OR (95% CI) Cases Controls OR (95% CI)
THM
< 10 139 951 1.00c 77 472 1.00c 52 450 1.00c
10–20 122 995 0.88 (0.67–1.17) 74 442 0.95 (0.65–1.40) 36 513 0.74 (0.46–1.20)
20–50 159 1,134 1.07 (0.83–1.39) 81 589 0.90 (0.63–1.29) 62 500 1.19 (0.79–1.81)
> 50 56 429 0.86 (0.58–1.28) 40 221 0.93 (0.56–1.55) 14 197 0.53 (0.25–1.12)
All 476 3,509 272 1,724 164 1,660
ptrend = 0.61 phetero = 0.46 ptrend = 0.74 phetero = 0.95 ptrend = 0.20 phetero = 0.057
BDCM
< 1 135 982 1.00c 72 493 1.00c  55 459 1.00c
1–3 128 968 1.00 (0.77–1.32) 63 498 0.86 (0.59–1.26) 53 432 1.15 (0.75–1.77)
3–5 114 852 0.95 (0.71–1.29) 68 396 0.96 (0.64–1.44) 32 427 0.81 (0.48–1.36)
> 5 99 707 0.91 (0.67–1.25) 69 337 1.06 (0.70–1.60) 24 342 0.65 (0.36–1.16)
All 476 3,509 272 1,724 164 1,660
ptrend = 0.54 phetero = 0.94 ptrend = 0.70 phetero = 0.80 ptrend = 0.095 phetero = 0.24
TCM
< 3 114 686 1.00c  63 356 1.00c  42 311 1.00c 
3–10 119 948 0.79 (0.59–1.06) 75 410 0.90 (0.60–1.36) 34 501 0.62 (0.37–1.03)
10–30 146 1,262 0.79 (0.60–1.05) 72 644 0.64 (0.43–0.95) 59 568 0.85 (0.54–1.36)
> 30 97 613 1.08 (0.78–1.50) 62 314 1.09 (0.70–1.70) 29 279 0.82 (0.46–1.46)
All 476 3,509 272 1,724 164 1,660
ptrend = 0.42 phetero = 0.13 ptrend = 0.86 phetero = 0.066 ptrend = 0.94 phetero = 0.32
ptrend is the p-value testing for linear trend in the exposure ORs based on the median THM level in each exposure group, and phetero is the p-value testing the hypothesis that all ORs are
equal to 1.0. 
aFull model adjusted for sex, age, province of recruitment, BMI, percent weight change, smoking, coffee, beer, liquor, total fat intake, and total energy intake. bFull model for females also
adjusted for age at ﬁrst menstruation and number of pregnancies; 44 female cases and 128 female controls were excluded because of missing data on menstrual or pregnancy history.
cReferent group. between subjects on municipal or nonmunici-
pal water sources (relative risk = 0.80; 95%
CI, 0.44–1.52). Koivusalo et al. (1997) fol-
lowed a cohort of 621,431 Finish residents
for 23 years and found no evidence of an
increased risk of pancreatic cancer (OR =
1.01; 95% CI, 0.70–1.20), with CDBP expo-
sure inferred on the basis of the mutagenicity
of communal water supplies.
Most previous studies estimated CDBP
exposure on the basis of information from a
single residence, under the assumption that
this accurately reﬂects exposures from previous
residences. In contrast, our study is based on
annual CDBP exposures derived from lifetime
residence histories. By linking each residence
to local water supply information, we were
able to account for regional variation in chlori-
nation practices and water sources. For one of
our two exposure classifications (the EHD
ﬁle), we were able to estimate exposure based
on measured CDBP levels in drinking water at
the time the person was living at the residence.
We compared the estimated mean THM
exposure using a 30-year ETW to that based
on exposure in the residence occupied 3 years
before interview. The two estimates demon-
strated a Pearson correlation coefﬁcient of r =
0.96, and the ORs obtained using these two
exposure estimates were generally similar and
nonsigniﬁcant. Exposure assessment based on
lifetime residence histories is preferred because
temporal variation in CDBP concentrations is
taken into account. Long-term average expo-
sure levels can provide a good indicator of life-
time risk, particularly if variation in exposure
levels over time is moderate (Goddard et al.
1995). The high correlation between results
based on our two exposure databases suggests
that previous studies based on a single estimate
taken at a time point before diagnosis can be
informative. The NECSS included a single
estimate of the amount of tap water drunk by
each subject. Although this did not permit a
complete estimation of water consumption at
the individual level because water contained in
preparation of food and beverages was not
considered, it did permit an analysis in which
exposures were weighted by the amount of tap
water consumed. This weighted analysis did
not yield statistically significant increases in
pancreatic cancer risk in relation to CDBP
intake (Table 4). Nor did our study find an
increased risk among people who reported
drinking higher numbers of glasses of tap
water per day (Table 1). Although it is possi-
ble that better measures of total water intake
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Table 3. ORs for pancreatic cancer in relation to THM concentrations in drinking water (based on the PMW data set, 30-year ETW, full OCMI imputation, varying
latencies, mean THM exposure levels).
THM concentration Male and femalea Malea Femaleb
(µg/L ) Cases Controls OR (95% CI) Cases Controls OR (95% CI) Cases Controls OR (95% CI)
3-Year latency
< 10 117 880 1.00c  63 433 1.00c  46 422 1.00c 
10–20 131 997 1.07 (0.80–1.43) 76 433 1.14 (0.76–1.70) 39 523 0.91 (0.56–1.48)
20–50 190 1,352 1.17 (0.91–1.52) 106 720 1.07 (0.75–1.52) 64 582 1.11 (0.72–1.71)
> 50 48 367 0.90 (0.58–1.40) 34 193 0.92 (0.53–1.62) 14 162 0.82 (0.37–1.80)
All 486 3,596 279 1,779 163 1,689
ptrend = 0.74 phetero = 0.50 ptrend = 0.72 phetero = 0.88 ptrend = 0.74 phetero = 0.77
8-Year latency
< 10 111 803 1.00c  64 399 1.00c  40 380 1.00c 
10–20 127 1,008 1.01 (0.75–1.35) 68 436 0.92 (0.61–1.38) 43 539 1.02 (0.62–1.66)
20–50 201 1,420 1.19 (0.91–1.54) 112 754 1.00 (0.70–1.43) 68 607 1.25 (0.80–1.95)
> 50 47 365 0.80 (0.51–1.24) 35 190 0.88 (0.51–1.51) 12 163 0.55 (0.23–1.28)
All 486 3,596 279 1,779 163 1,689
ptrend = 0.45 phetero = 0.21 ptrend = 0.69 phetero = 0.92 ptrend = 0.28 phetero = 0.22
13-Year latency
< 10 110 746 1.00c  60 372 1.00c  41 351 1.00c 
10–20 123 1,012 0.88 (0.67–1.18) 72 435 0.97 (0.65–1.46) 41 542 0.82 (0.50–1.33)
20–50 205 1,479 1.11 (0.85–1.44) 110 782 0.98 (0.68–1.41) 70 639 1.12 (0.72–1.74)
> 50 48 359 0.77 (0.49–1.19) 37 190 0.91 (0.52–1.56) 11 157 0.46 (0.19–1.10)
All 486 3,596 279 1,779 163 1,689
ptrend = 0.39 phetero = 0.17 ptrend = 0.72  phetero = 0.99 ptrend = 0.16 phetero = 0.13
ptrend is the p-value testing for linear trend in the exposure ORs based on the median THM level in each exposure group, and phetero is the p-value testing the hypothesis that all ORs are
equal to 1.0. 
aFull model adjusted for sex, age, province of recruitment, BMI, percent weight change, smoking, coffee, beer, liquor, total fat intake, and total energy intake. bFull model for females also
adjusted for age at ﬁrst menstruation and number of pregnancies; 44 female cases and 128 female controls were excluded because of missing data on menstrual or pregnancy history.
cReferent group.
Table 4. Effect of THM exposure on risk of pancreatic cancer (based on the PMW data set, full OCMI imputation, weighted by drinking water intake, mean THM
exposure levels).
THM concentration Male and femalea Malea Femaleb
(µg/L) Cases Controls OR (95% CI) Cases Controls OR (95% CI) Cases Controls OR (95% CI)
Quartile 1c 115 885 1.00d  64 442 1.00d  42 412 1.00d 
Quartile 2 116 915 1.07 (0.80–1.43) 64 459 0.94 (0.63–1.40) 38 425 1.09 (0.67–1.78)
Quartile 3 125 909 1.15 (0.86–1.53) 65 425 1.01 (0.68–1.51) 47 454 1.20 (0.75–1.92)
Quartile 4A 70 447 1.18 (0.85–1.65) 46 228 1.23 (0.80–1.91) 19 198 0.95 (0.52–1.74)
Quartile 4B 60 440 0.90 (0.62–1.33) 40 225 0.87 (0.53–1.43) 17 200 0.77 (0.38–1.55)
All 486 3,596 279 1,779 163 1,689
Ptrend = 0.72 Phetero = 0.64 Ptrend = 0.79 Phetero = 0.69 Ptrend = 0.46 Phetero = 0.77
ptrend is the p-value testing for linear trend in the exposure ORs based on the median THM level in each exposure group, and phetero is the p-value testing the hypothesis that all ORs are
equal to 1.0. 
aFull model adjusted for sex, age, province of recruitment, BMI, percent weight change, smoking, coffee, beer, liquor, total fat intake, and total energy intake. bFull model for females also
adjusted for age at ﬁrst menstruation and number of pregnancies; 44 female cases and 128 female controls were excluded because of missing data on menstrual or pregnancy history.
cQuartiles were deﬁned based on distribution of exposure estimates in combined sample based on the 30-year ETW with 3-year latency weighted by self-reported intake of drinking
water; quartile 4 was subdivided into two groups based on the median exposure in the quartile. dReferent group.Article | Do et al.
424 VOLUME 113 | NUMBER 4 | April 2005 • Environmental Health Perspectives
could yield more refined exposure estimates
that would reveal some misclassification of
total lifetime CDBP exposure in our study,
the lack of suggestive evidence for any impact
on risk of adjustment for tap water intake
makes it unlikely that our analysis is missing
important risk effects.
In addition to ingestion, people can be
exposed to CDBPs from two other routes:
inhalation and dermal contact. Although we
had no information on which to estimate
exposure from these alternate routes, evidence
suggests that these routes of exposure could be
important sources of CDBP exposure. In par-
ticular, Backer et al. (2000) found that a
10-min shower led to higher blood levels of
CDBPs than did drinking 1 L of water. Hence,
it is likely that our study, like all previous stud-
ies that have considered CDBP exposure only
by ingestion, has underestimated total CDBP
exposure. However, the analyses we performed
were based on the rank ordering of intake, not
on absolute intake levels. If this rank ordering
is unaltered by the inclusion of dermal and
inhalation exposure to CDBP, our risk esti-
mates would remain valid. Nonetheless, con-
sideration of CDBP exposures from multiple
routes would be useful in future studies.
Although total THM levels are widely
accepted as a marker of total CDBP concentra-
tions, drinking water contains > 100 CDBPs.
The present study is based on information on
only three (THM, TCM, and BDCM) of the
many known CDBPs. If other CDBPs demon-
strate carcinogenic potency greater than that of
THMs, TCMs, or BDCMs, it is possible that
drinking water may be associated with cancer
risk. However, because no association was
found between intake of tap water and pancre-
atic cancer risk, the present study does not sug-
gest the presence of other more potent CDBPs
in drinking water. This hypothesis is sup-
ported by the lack of an association between
the mutagenicity of drinking water and cancer
risk (Koivusalo et al. 1997). Nonetheless, the
possibility that there may exist a potent car-
cinogenic CDBP present at low levels in
drinking water cannot be ruled out.
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